Phase 2 InCor Hypertension Study Approved

InCor Hospital has received approval to begin a large scale Phase 2 Hypertension Study using Avatr. The study will evaluate benefits of Avatr technology to support patient engagement, improved quallity-of-life, improved clinical outcomes and cost savings.

michael wilkinson